跳至主要内容
临床试验/NL-OMON32245
NL-OMON32245撤回2 期

Rheos Diastolic Heart Failure Trial - CVRx DHF trail

Academisch Ziekenhuis Maastricht0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Be at least 21 years of age.
  • 2. Have bilateral carotid bifurcations that are below the level of the mandible.
  • 3. Have a left ventricular ejection fraction * 45% within 30 days of enrollment.
  • 4. Within 24 months prior to enrollment, hospital admission for heart failure or at least 2 of the signs/symptoms of heart failure that resolved on heart failure treatment.
  • 5. NYHA Class II-III classification within 30 days prior to enrollment
  • 6. Have an office cuff systolic blood pressure greater than or equal to 140 mmHg within 30 days prior to enrollment.

排除标准

  • 1. Have known or suspected baroreflex failure or autonomic neuropathy.
  • 2. Have an arm circumference greater than 46 cm and/or a body mass index of greater than 45.
  • 3. Have significant uncontrolled symptomatic bradyarrhythmias with a heart rate < 60 bpm.
  • 4. Significant orthostatic hypotension.
  • 5. Had a myocardial infarction or cerebral vascular accident within 3 months prior to enrollment.

研究者

相似试验